CCM
Copernicus Capital Management Portfolio holdings
AUM
$8.26M
This Quarter Return
-4.74%
1 Year Return
+37.91%
3 Year Return
+125.34%
5 Year Return
–
10 Year Return
–
AUM
$82.6M
AUM Growth
+$82.6M
(+8.3%)
Cap. Flow
+$7.68M
Cap. Flow
% of AUM
9.3%
Top 10 Holdings %
Top 10 Hldgs %
89%
Holding
21
New
6
Increased
3
Reduced
5
Closed
7
Top Buys
| 1 |
CVS Health
CVS
|
$7.71M |
| 2 |
McKesson
MCK
|
$6.9M |
| 3 |
Biogen
BIIB
|
$5.7M |
| 4 |
Centene
CNC
|
$2.79M |
| 5 |
Cigna
CI
|
$2.61M |
Top Sells
| 1 |
AbbVie
ABBV
|
$6.81M |
| 2 |
IQVIA
IQV
|
$6.27M |
| 3 |
SIEN
Sientra, Inc.
SIEN
|
$3.44M |
| 4 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$1.96M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$1.76M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Vertex Pharmaceuticals
VRTX
$103B
| $12.5M | 15.1% |
52,453
-5,362
| -9% | -$1.28M |
|
2
Bristol-Myers Squibb
BMY
$97.4B
| $9.87M | 11.94% |
176,997
+44,165
| +33% | +$2.46M |
|
|
3
Cigna
CI
$80.1B
| $9.7M | 11.74% |
54,748
+14,748
| +37% | +$2.61M |
|
|
4
BioMarin Pharmaceuticals
BMRN
$11.4B
| $8.72M | 10.55% |
103,179
-20,779
| -17% | -$1.76M |
|
|
5
CVS Health
CVS
$94.2B
| $7.71M | 9.33% |
+130,000
| New | +$7.71M |
|
|
6
McKesson
MCK
$86.3B
| $6.9M | 8.35% |
+51,000
| New | +$6.9M |
|
|
7
Biogen
BIIB
$20.8B
| $5.7M | 6.89% |
+18,000
| New | +$5.7M |
|
8
Thermo Fisher Scientific
TMO
$184B
| $5.36M | 6.48% |
18,896
+8,937
| +90% | +$2.53M |
|
9
Fate Therapeutics
FATE
$119M
| $3.58M | 4.33% |
160,959
-1,018
| -0.6% | -$22.6K |
|
10
Zoetis
ZTS
$67.7B
| $3.55M | 4.29% |
30,125
-190
| -0.6% | -$22.4K |
|
|
11
Centene
CNC
$14.6B
| $2.79M | 3.38% |
+47,000
| New | +$2.79M |
|
12
Tandem Diabetes Care
TNDM
$878M
| $2.75M | 3.32% |
42,685
-7,315
| -15% | -$471K |
|
|
ARNA
13
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.89M | 2.29% |
+45,000
| New | +$1.89M |
|
|
SWAV
14
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $1.66M | 2.01% |
+50,000
| New | +$1.66M |
|
|
15
AbbVie
ABBV
$376B
| – | – |
-76,957
| Closed | -$6.81M |
|
16
Ascendis Pharma
ASND
$12.2B
| – | – |
-12,000
| Closed | -$1.67M |
|
17
Humana
HUM
$37.3B
| – | – |
-3,942
| Closed | -$1.45M |
|
18
Illumina
ILMN
$15.3B
| – | – |
-4,309
| Closed | -$1.43M |
|
|
19
IQVIA
IQV
$31.4B
| – | – |
-40,585
| Closed | -$6.27M |
|
|
KRTX
20
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| – | – |
-26,000
| Closed | -$1.96M |
|
|
SIEN
21
DELISTED
Sientra, Inc.
SIEN
| – | – |
-384,809
| Closed | -$3.44M |
|